Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 88, Issue 2, Pages 234-237Publisher
WILEY-LISS
DOI: 10.1002/jcb.10341
Keywords
vitamin D receptor; AOK-B50; half-life; cycloheximide; actinomycin D
Categories
Ask authors/readers for more resources
The 25-hydroxyvitamin D-3-24-hydroxylase mRNA is tightly and reciprocally regulated by 1,25dihydroxyvitamin D-3 (1,25(OH)(2)D-3) and parathyroid hormone (PTH). The upregulation of the 24-hydroxylase by 1,25(OH)(2)D-3 is well established and occurs at the transcriptional level through two vitamin D response elements in the promoter of the gene. However, this induction is blocked by the protein synthesis inhibitor cycloheximide (CHX) indicatinga protein component in the regulation pathway. CHX treatment reduced total vitamin D receptor(VDR) protein levels in cells, but reintroduction of VDR and/or retinoid X receptor protein into cells by transfection did not reduce the inhibition by CHX. This indicates that production of another transcription factor or mRNA-stabilizing protein synthesized in response to 1,25(OH)(2)D-3 is required for optimal accumulation of 24-hydroxylase mRNA. PTH down-regulates the 24-hydroxylase mRNA by affecting its stability. The half-life of 24-hydroxylase mRNA is reduced 4.2-fold in AOK-B50 cells by PTH. Untranslated regions of the 24-hydroxylase mRNA in reporter gene assays did not confer PTH responsiveness. Further analysis of the coding region of the rat 24-hydroxylase may reveal sites of action of PTH. (C) 2002Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available